Trials / Completed
CompletedNCT02972125
A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects
A Single-Center, Open-Label, Randomized, Single-Oral Dose, 2-Way Cross-Over Study to Investigate the Bioequivalence Between Lacosamide Tablet and Dry Syrup in Healthy Male Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- UCB Biopharma S.P.R.L. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a study designed to demonstrate the Bioequivalence between Lacosamide (LCM) Tablet and Dry Syrup in Healthy Male Japanese Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lacosamide (LCM) tablet | Treatment A: Single dose of Lacosamide (LCM) 100 mg tablet |
| DRUG | Lacosamide (LCM) dry syrup | Treatment B: Single dose of Lacosamide (LCM) 100 mg given as dry syrup |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2016-11-23
- Last updated
- 2017-03-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02972125. Inclusion in this directory is not an endorsement.